The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S)-N-[(R)-[4-(Cyclobutylmethoxy)phenyl](([(thiophen-2-yl)methyl]carbamoyl))methyl]-2-phenylpropanamide ID: ALA4789643
PubChem CID: 162669578
Max Phase: Preclinical
Molecular Formula: C27H30N2O3S
Molecular Weight: 462.62
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C[C@H](C(=O)N[C@@H](C(=O)NCc1cccs1)c1ccc(OCC2CCC2)cc1)c1ccccc1
Standard InChI: InChI=1S/C27H30N2O3S/c1-19(21-9-3-2-4-10-21)26(30)29-25(27(31)28-17-24-11-6-16-33-24)22-12-14-23(15-13-22)32-18-20-7-5-8-20/h2-4,6,9-16,19-20,25H,5,7-8,17-18H2,1H3,(H,28,31)(H,29,30)/t19-,25+/m0/s1
Standard InChI Key: VCSASDIQULIQAP-UQBPGWFLSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
13.1975 -29.2496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1963 -30.0692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9044 -30.4781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6140 -30.0687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6112 -29.2460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9026 -28.8408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3174 -28.8348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0266 -29.2407 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7328 -28.8294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4420 -29.2354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1482 -28.8241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4451 -30.0526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7297 -28.0123 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8534 -29.2318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5591 -28.8212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5565 -28.0031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8422 -27.5974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1395 -28.0103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3143 -28.0176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4883 -30.4772 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7809 -30.0680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7815 -29.2509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0204 -27.6063 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6050 -27.6117 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6020 -26.7945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3081 -26.3832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0565 -26.7107 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
16.6010 -26.1013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1897 -25.3951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3911 -25.5681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3576 -28.6731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7802 -28.0948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2019 -28.6722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
10 12 1 6
9 13 2 0
11 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 11 1 0
7 19 1 6
2 20 1 0
20 21 1 0
21 22 1 0
19 23 2 0
19 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 26 2 0
22 31 1 0
31 32 1 0
32 33 1 0
33 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 462.62Molecular Weight (Monoisotopic): 462.1977AlogP: 5.20#Rotatable Bonds: 10Polar Surface Area: 67.43Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.01CX Basic pKa: ┄CX LogP: 5.11CX LogD: 5.11Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.43Np Likeness Score: -1.38
References 1. Rahman MT,Decker AM,Langston TL,Mathews KM,Laudermilk L,Maitra R,Ma W,Darcq E,Kieffer BL,Jin C. (2020) Design, Synthesis, and Structure-Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists., 63 (23): [PMID:33205975 ] [10.1021/acs.jmedchem.0c01581 ]